Companies: 10,795·Total market cap: $144.5T
Elutia Inc.

Elutia Inc.

ELUTNASDAQHealthcare● Active
$0.99
$-0.01(-0.85%)
Market Cap$43774995
P/E Ratio
52W High$2.64
52W Low$0.5
Overview

Elutia Inc. (ELUT) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

elut · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Elutia Inc. (ELUT) measures how much investors pay for each dollar of the company's trailing earnings. ELUT's current PE ratio of 0.85x is calculated by dividing its stock price of $0.99 by its TTM earnings per share of $1.16. +58.2% elevated vs 5Y avg 0.5x

0.85x
P/E Ratio (TTM)+58.2%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.60
Based on 1 analyst
EPS (TTM)
$1.16
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Elutia Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2018 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 0.5x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Elutia Inc.
Elutia Inc.You
ELUT
$44M0.85x$1.16
Annovis Bio, Inc.
Annovis Bio, Inc.
ANVS
$35MN/A-$1.40
BioAtla, Inc.
BioAtla, Inc.
BCAB
$4MN/A-$50.66
CalciMedica, Inc.
CalciMedica, Inc.
CALC
$15MN/A-$0.00
Celularity Inc.
Celularity Inc.
CELU
$20MN/A-$3.59
Lantern Pharma Inc.
Lantern Pharma Inc.
LTRN
$48MN/A-$1.57
MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc.
MAIA
$77MN/A-$0.70

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 8 of 8 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
0.54x$1.29
2024-12-31
FY2024
$-1.86
2023-12-31
FY2023
$-2.07
2022-12-31
FY2022
$-2.38
2021-12-31
FY2021
$-2.38
2020-12-31
FY2020
$-2.13
2019-12-31
FY2019
$-1.12
2018-12-31
FY2018
$-1.08

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Elutia Inc. (ELUT) measures how much investors pay for each dollar of the company's trailing earnings. ELUT's current PE ratio of 0.85x is calculated by dividing its stock price of $0.99 by its TTM earnings per share of $1.16.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.99 ÷ $1.16 = 0.85x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ELUT pe ratio · 6 questions

ELUT's current PE ratio is 0.85x as of 2026-06-09, based on a stock price of $0.99 and TTM EPS of $1.16. Data sourced from Financial Modeling Prep via ELUT's SEC 10-K and 10-Q filings.

ELUT PE ratioWhat is ELUT PE ratioCurrent PE ratio of ELUTELUT PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Elutia Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09